CVE-2023-33365
Published: 03 August 2023
Summary
CVE-2023-33365 is a high-severity Path Traversal (CWE-22) vulnerability in Supremainc Biostar 2. Its CVSS base score is 7.5 (High).
Operationally, ranked in the top 34.5% of CVEs by exploit likelihood; it is not currently listed in the CISA KEV catalog.
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2023-37528
Vulnerability details
A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to fetch arbitrary files from the server's web server.
- CWE(s)
Related Threats
No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.
Affected Assets
Mitigating Controls
Likely Mitigating Controls AI
Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.
Validates pathnames and filenames to prevent traversal outside intended directories.